AI 2020: the global state of intelligent enterprise
This cross-sector report from AIIA.net explores the future landscape of intelligent enterprise, offering a deep-dive study into which sectors are set to benefit the most from artificial intelligence and why the perceived challenges are as numerous as they are diverse.
Add bookmark
We respect your privacy, by clicking "Download Your Copy" you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. You have the right to object. In addition, you will receive our e-newsletter, including information on related online learning opportunities. For further information on how we process and monitor your personal data, and information about your privacy and opt-out rights, click here.
What does the intelligent enterprise of the future look like? How will pharma benefit from artificial intelligence? And how many pharma manufacturers are in the planning stages of their AI journey?
You may have seen our Biomanufacturing Market Report which looked at the trends and opportunities in biomanufacturing. This report contains valuable comparisons with other industries such as Defence, Customer Experience, and Energy. See which sectors are benefiting the most from artificial intelligence and what the future holds.
Keen to stay on—or ahead of—the curve, many pharma organizations are looking to the latest intelligent enterprise (IE) tools to solve drug discovery challenges, increase productivity and benefit the bottom line.
Responsive leaders are looking for innovative ways to leverage tools such as intelligent automation, machine learning and predictive analytics, which are fast gaining momentum in the marketplace.
The message, for those who’ve chosen to listen, is loud and clear: the intelligence revolution is here - disrupt or be disrupted.
